[
  {
    "id": "303",
    "question_id": "303",
    "document_id": "303",
    "question": "At this point the best disposal are:",
    "type": "multiple_choice",
    "choices": [
      "Surgical treatment as soon as possible",
      "Cherrie chemotherapy",
      "Can be observed on a regular basis to see if it changes",
      "Do not ignore it completely"
    ],
    "context": "",
    "answer": [
      "Surgical treatment as soon as possible"
    ],
    "entity": "1. Surgical treatment\n2. Chemotherapy \n3. Observation \n4. Changes",
    "prediction": "C",
    "path": [],
    "neighbor_input": "Reranked Triple1: obesity \u2014\u2014> treats \u2014\u2014> hypertension\nReranked Triple2: obesity \u2014\u2014> causes \u2014\u2014> cognitive decline\nReranked Triple3: obesity \u2014\u2014> causes \u2014\u2014> cerebromicrovascular damage\nReranked Triple4: obesity \u2014\u2014> causes \u2014\u2014> AD\nReranked Triple5: obesity \u2014\u2014> causes \u2014\u2014> inflammation",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'obesity' treats 'hypertension'.\nNeighbor-based Evidence 2: 'obesity' causes 'cognitive decline'.\nNeighbor-based Evidence 3: 'obesity' causes 'cerebromicrovascular damage'.\nNeighbor-based Evidence 4: 'obesity' causes 'AD'.\nNeighbor-based Evidence 5: 'obesity' causes 'inflammation'.",
    "entity_confidence_scores": [
      0.7945061922073364,
      0.6155421733856201,
      0.6155421733856201,
      0.8786677122116089,
      0.7727140188217163,
      0.7676684856414795,
      0.7847082018852234,
      0.7243226170539856,
      1.0000001192092896,
      0.6588581800460815,
      0.6320681571960449,
      0.5570054054260254,
      0.7383591532707214,
      0.7189934253692627,
      1.0,
      0.8226057291030884,
      0.5825430154800415,
      0.5825430154800415,
      0.6544378995895386,
      1.0,
      0.6973943114280701,
      0.6542156934738159,
      1.0,
      0.6197653412818909,
      0.6542156934738159,
      0.5825430154800415,
      0.6294437646865845,
      1.0000001192092896,
      0.7212753295898438,
      0.7677667140960693,
      1.0
    ],
    "question_types": [
      "exception"
    ],
    "umls_normalized_entities": [
      "surgical treatment recommended",
      "Chemotherapy",
      "Patient observation",
      "Body Weight Changes"
    ],
    "umls_semantic_variants": [
      [
        "Surgical treatment",
        "surgical treatment recommended",
        "surgical treatment recommended (history)"
      ],
      [
        "Chemotherapy",
        "\u0627\u0644\u0645\u0639\u0627\u0644\u062c\u0627\u062a \u0627\u0644\u0643\u064a\u0645\u064a\u0627\u0626\u064a\u0629",
        "chemokuur"
      ],
      [
        "Observation",
        "pe\u010dliv\u00e9 sledov\u00e1n\u00ed",
        "patient observation (treatment)"
      ]
    ],
    "enhanced_entity_links": {},
    "adaptive_knowledge_count": 112,
    "hierarchical_contexts": {
      "Surgical treatment": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      },
      "Chemotherapy": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      },
      "Observation": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      }
    },
    "multi_hop_paths_count": 0
  },
  {
    "id": "308",
    "question_id": "308",
    "document_id": "308",
    "question": "A 72-year-old man with mild dementia, cognitive disorder is progressive and gradual deterioration occurs, slow easy to fall, occasional confusion consciousness and hallucinations, but no incontinence. Physical examination torso stiff, no shaking. CT scan showed generalized cerebral atrophy, show mild generalized EEG cortical dysfunction. Which of the following is most likely to patients suffering from the disease?",
    "type": "multiple_choice",
    "choices": [
      "Lewy body dementia (dementia with Lewy body)",
      "Ezihaimo disease (Alzheimer's disease)",
      "Normal pressure hydrocephalus (normal pressure hydrocephalus)",
      "CJD (Creutzfeldt-Jakob disease)"
    ],
    "context": "",
    "answer": [
      "Lewy body dementia (dementia with Lewy body)"
    ],
    "entity": "1. age: 72\n2. condition: mild dementia\n3. symptom: progressive and gradual deterioration\n4. symptom: slow easy to fall\n5. symptom: occasional confusion consciousness\n6. symptom: hallucinations\n7. symptom: no incontinence\n8. examination finding: torso stiff\n9. examination finding: no shaking\n10. imaging finding: cerebral atrophy\n11. imaging finding: mild generalized EEG cortical dysfunction\n12. disease: Lewy body dementia (dementia with Lewy body)\n13. disease: Ezihaimo disease (Alzheimer's disease)\n14. disease: Normal pressure hydrocephalus (normal pressure hydrocephalus)\n15. disease: CJD (Creutzfeldt-Jakob disease)",
    "prediction": "A",
    "path": "Reranked Triple1: cortical dysfunction \u2014\u2014> ASSOCIATES \u2014\u2014> patients\nReranked Triple2: patients \u2014\u2014> have \u2014\u2014> Lewy body dementia\nReranked Triple3: patients \u2014\u2014> died from \u2014\u2014> iatrogenic Creutzfeldt-Jakob disease\nReranked Triple4: iatrogenic Creutzfeldt-Jakob disease \u2014\u2014> resembles \u2014\u2014> prion diseases\nReranked Triple5: prion diseases \u2014\u2014> ASSOCIATES \u2014\u2014> Alzheimer's disease",
    "neighbor_input": "Reranked Triple1: hallucinations \u2014\u2014> accompanies \u2014\u2014> dementia\nReranked Triple2: delirium \u2014\u2014> cause \u2014\u2014> neuronal damage\nReranked Triple3: delirium \u2014\u2014> associates \u2014\u2014> cognitive impairment\nReranked Triple4: dementia syndrome \u2014\u2014> type \u2014\u2014> aphasia",
    "response_of_KG_list_path": "Path-based Evidence 1: 'cortical dysfunction' ASSOCIATES 'patients'\nPath-based Evidence 2: 'patients' have 'Lewy body dementia'\nPath-based Evidence 3: 'patients' died from 'iatrogenic Creutzfeldt-Jakob disease'\nPath-based Evidence 4: 'iatrogenic Creutzfeldt-Jakob disease' resembles 'prion diseases'\nPath-based Evidence 5: 'prion diseases' ASSOCIATES 'Alzheimer's disease'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'hallucinations' accompanies 'dementia'\nNeighbor-based Evidence 2: 'delirium' causes 'neuronal damage'\nNeighbor-based Evidence 3: 'delirium' associates with 'cognitive impairment'\nNeighbor-based Evidence 4: 'dementia syndrome' is a type of 'aphasia'",
    "entity_confidence_scores": [
      0.7034363746643066,
      0.8133509755134583,
      0.6715081930160522,
      0.6544328331947327,
      1.0,
      0.795051634311676,
      0.8674484491348267,
      0.7119930982589722,
      0.7710253596305847,
      0.8571323752403259,
      0.68231201171875,
      0.885833740234375,
      0.7674967050552368,
      1.000000238418579,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8598015308380127,
      0.955716609954834,
      1.0,
      1.000000238418579,
      0.9889410138130188,
      0.7598437070846558,
      0.929362416267395,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      0.929362416267395,
      1.0,
      1.0,
      0.9129931926727295,
      0.9031563401222229,
      1.0000001192092896,
      0.903645396232605,
      0.8473215699195862,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      0.7383591532707214,
      0.7583372592926025,
      1.0,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      0.9736135005950928,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0,
      0.8812066912651062,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.6479500532150269,
      1.0000001192092896,
      0.6894932985305786
    ],
    "question_types": [
      "symptom",
      "diagnosis"
    ],
    "umls_normalized_entities": [
      "Avobenzone 30 mg in 1 mL / Homosalate 50 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 72 mg in 1 mL TOPICAL LOTION [LOreal Paris Wrinkle Expert Age Defense 55 Plus Broad Spectrum SPF 30 Sunscreen]",
      "condition: mild dementia",
      "symptom: progressive and gradual deterioration",
      "symptom: slow easy to fall",
      "symptom: occasional confusion consciousness",
      "Hallucinations",
      "symptom: no incontinence",
      "examination finding: torso stiff",
      "examination finding: no shaking",
      "imaging finding: cerebral atrophy",
      "imaging finding: mild generalized EEG cortical dysfunction",
      "Non-Alzheimer's dementia (e.g., Lewy body dementia, vascular or multi-infarct dementia; mixed dementia; frontotemporal dementia such as Pick's disease; and dementia related to stroke, Parkinson's or Creutzfeldt-Jakob diseases)",
      "disease: Ezihaimo disease (Alzheimer's disease)",
      "disease: Normal pressure hydrocephalus (normal pressure hydrocephalus)",
      "Creutzfeldt-Jakob disease"
    ],
    "umls_semantic_variants": [
      [
        "age: 72",
        "Avobenzone 30 mg in 1 mL / Homosalate 50 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 72 mg in 1 mL TOPICAL LOTION [LOreal Paris Wrinkle Expert Age Defense 55 Plus Broad Spectrum SPF 30 Sunscreen]"
      ],
      [
        "condition: mild dementia"
      ],
      [
        "symptom: progressive and gradual deterioration"
      ]
    ],
    "enhanced_entity_links": {},
    "adaptive_knowledge_count": 77,
    "hierarchical_contexts": {
      "age: 72": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      },
      "condition: mild dementia": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      },
      "symptom: progressive and gradual deterioration": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      }
    },
    "multi_hop_paths_count": 0
  },
  {
    "id": "553",
    "question_id": "553",
    "document_id": "553",
    "question": "Stellate cell collagen related to the central nervous system (astrocyte) response to injury, the Which statement is correct?",
    "type": "multiple_choice",
    "choices": [
      "Gum degeneration (gliosis) collagen only stellate cell proliferation (hyperplasia) without hypertrophy (hypertrophy)",
      "Azihaimo second type (Alzheimer type \u2161) stellate cells mainly seen Ezihaimo collagen disease (Alzheimer disease)",
      "Rosen Saybolt fiber (Rosenthal fibers) is common in hairy cell astrocytoma (pilocytic astrocytoma)",
      "Starch bodies (corpora amylacea) at substantially the same probability of different ages of patients seen"
    ],
    "context": "",
    "answer": [
      "Rosen Saybolt fiber (Rosenthal fibers) is common in hairy cell astrocytoma (pilocytic astrocytoma)"
    ],
    "entity": "1. Stellate cell collagen\n2. Central nervous system\n3. Astrocyte\n4. Injury\n5. Gum degeneration\n6. Gliosis\n7. Proliferation\n8. Hyperplasia\n9. Hypertrophy\n10. Azihaimo second type\n11. Alzheimer type \u2161\n12. Ezihaimo collagen disease\n13. Alzheimer disease\n14. Rosen Saybolt fiber\n15. Rosenthal fibers\n16. Hairy cell astrocytoma\n17. Pilocytic astrocytoma\n18. Starch bodies\n19. Corpora amylacea",
    "prediction": "C",
    "path": "Reranked Triple1: astrocytes \u2014\u2014> secretes \u2014\u2014> insulin  \nReranked Triple2: Alzheimer's disease \u2014\u2014> caused by \u2014\u2014> trauma  \nReranked Triple3: Alzheimer's dementia \u2014\u2014> ASSOCIATES \u2014\u2014> dementia  \nReranked Triple4: neuronal death \u2014\u2014> causes \u2014\u2014> injury  \nReranked Triple5: trauma \u2014\u2014> causes \u2014\u2014> sepsis  ",
    "neighbor_input": "Reranked Triple1: nervous system \u2014\u2014> affects \u2014\u2014> neurodegenerative disorders,Alzheimer's disease  \nReranked Triple2: nervous system \u2014\u2014> has \u2014\u2014> neuron  \nReranked Triple3: nervous system \u2014\u2014> regulates \u2014\u2014> neuroinflammation  \nReranked Triple4: nervous system \u2014\u2014> LOCATION OF \u2014\u2014> neuroblastoma  \nReranked Triple5: nervous system \u2014\u2014> ASSOCIATES \u2014\u2014> Alzheimer's disease  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Astrocytes' 'secretes' 'insulin'.\n\nPath-based Evidence 2: 'Alzheimer's disease' 'caused by' 'trauma'.\n\nPath-based Evidence 3: 'Alzheimer's dementia' 'ASSOCIATES' 'dementia'.\n\nPath-based Evidence 4: 'Neuronal death' 'causes' 'injury'.\n\nPath-based Evidence 5: 'Trauma' 'causes' 'sepsis'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The 'nervous system' 'affects' 'neurodegenerative disorders' and 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: The 'nervous system' 'has' 'neuron'.\n\nNeighbor-based Evidence 3: The 'nervous system' 'regulates' 'neuroinflammation'.\n\nNeighbor-based Evidence 4: The 'nervous system' 'LOCATION OF' 'neuroblastoma'.\n\nNeighbor-based Evidence 5: The 'nervous system' 'ASSOCIATES' with 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      0.7163963317871094,
      1.0,
      1.0000001192092896,
      0.867530345916748,
      0.739099383354187,
      0.7357243299484253,
      1.000000238418579,
      1.000000238418579,
      0.8337712287902832,
      0.8337712287902832,
      1.0,
      1.0000001192092896,
      0.9092804193496704,
      0.6104243397712708,
      0.9999999403953552,
      0.9999999403953552,
      1.0,
      0.7505702376365662,
      1.0000001192092896,
      0.8343555927276611,
      1.000000238418579,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      0.6615894436836243,
      0.7058168053627014,
      0.6280163526535034,
      0.7526968121528625,
      1.0,
      0.9736135005950928,
      1.000000238418579,
      1.0,
      1.0000001192092896,
      0.9129931926727295,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.8812066912651062,
      1.0000001192092896,
      1.000000238418579,
      0.7583282589912415,
      1.000000238418579,
      0.7306473255157471,
      0.7306473255157471,
      1.0000001192092896,
      0.7962216138839722,
      0.7333775758743286,
      0.6422242522239685,
      1.0,
      1.0,
      0.9096423983573914,
      1.0,
      0.7249053120613098,
      1.0,
      0.7557580471038818,
      0.9999999403953552,
      0.7725558280944824,
      1.0000001192092896,
      0.7518824338912964,
      0.7470306158065796,
      0.8395751714706421,
      1.0,
      1.0,
      0.834135115146637,
      0.8746947050094604,
      1.0,
      1.0,
      0.9031563401222229,
      1.0000001192092896,
      0.903645396232605,
      0.8473215699195862,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      0.7383591532707214,
      0.7320890426635742,
      1.0,
      1.0,
      0.8812066912651062,
      0.7079567909240723,
      0.6200331449508667,
      0.633277952671051,
      0.7375537753105164
    ],
    "question_types": [
      "general"
    ],
    "umls_normalized_entities": [
      "Stellate cell collagen",
      "Central Nervous System",
      "Fibrillary astrocyte",
      "Traumatic injury",
      "Gum degeneration",
      "Gliosis",
      "Proliferation",
      "Hyperplasia",
      "Hypertrophy",
      "Azihaimo second type",
      "Alzheimer type \u2161",
      "Ezihaimo collagen disease",
      "familial Alzheimer disease",
      "Rosen Saybolt fiber",
      "Rosenthal Fibers Present",
      "Hairy cell astrocytoma",
      "Pilocytic Astrocytoma",
      "Starch bodies",
      "Corpora amylacea"
    ],
    "umls_semantic_variants": [
      [
        "Stellate cell collagen"
      ],
      [
        "Central nervous system",
        "Centraal zenuwstelsel",
        "Systems, Central Nervous"
      ],
      [
        "Astrocyte",
        "fibrillary astrocyte",
        "Fibrous astrocyte"
      ]
    ],
    "enhanced_entity_links": {},
    "adaptive_knowledge_count": 318,
    "hierarchical_contexts": {
      "Stellate cell collagen": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      },
      "Central nervous system": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      },
      "Astrocyte": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      }
    },
    "multi_hop_paths_count": 0
  },
  {
    "id": "554",
    "question_id": "554",
    "document_id": "554",
    "question": "40 year old man with acute mental disorders, diagnosis is most unlikely:",
    "type": "multiple_choice",
    "choices": [
      "Ezihaimo disease (Alzheimer disease)",
      "Subdural hematoma",
      "Winnick's encephalopathy (Wernicke's encephalopathy)",
      "Depression"
    ],
    "context": "",
    "answer": [
      "Ezihaimo disease (Alzheimer disease)"
    ],
    "entity": "1. acute mental disorders\n2. Alzheimer disease (Ezihaimo disease)\n3. Subdural hematoma\n4. Winnick's encephalopathy (Wernicke's encephalopathy)\n5. Depression",
    "prediction": "B",
    "path": "Reranked Triple1: Depression \u2014\u2014> associates \u2014\u2014> dementia\nReranked Triple2: Senile Dementia \u2014\u2014> causes \u2014\u2014> patients\nReranked Triple3: Depression \u2014\u2014> treats \u2014\u2014> Abeta\nReranked Triple4: Alzheimer's disease type dementia \u2014\u2014> associates \u2014\u2014> dementia\nReranked Triple5: Alzheimer's dementia \u2014\u2014> associates \u2014\u2014> dementia",
    "neighbor_input": "Reranked Triple1: Alzheimer diseases \u2014\u2014> neurodegenerative diseases\nReranked Triple2: Alzheimer diseases \u2014\u2014> neuroinflammation\nReranked Triple3: Alzheimer diseases \u2014\u2014> cognitive decline\nReranked Triple4: Alzheimer diseases \u2014\u2014> memory impairment\nReranked Triple5: Alzheimer diseases \u2014\u2014> behavior abnormalities",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Depression' associates with 'dementia'.\nPath-based Evidence 2: 'Senile Dementia' causes 'patients'.\nPath-based Evidence 3: 'Depression' treats 'Abeta'.\nPath-based Evidence 4: 'Alzheimer's disease type dementia' associates with 'dementia'.\nPath-based Evidence 5: 'Alzheimer's dementia' associates with 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer diseases' is related to 'neurodegenerative diseases'.\n\nNeighbor-based Evidence 2: 'Alzheimer diseases' is related to 'neuroinflammation'.\n\nNeighbor-based Evidence 3: 'Alzheimer diseases' is related to 'cognitive decline'.\n\nNeighbor-based Evidence 4: 'Alzheimer diseases' is related to 'memory impairment'.\n\nNeighbor-based Evidence 5: 'Alzheimer diseases' is related to 'behavior abnormalities'.",
    "entity_confidence_scores": [
      0.7530063390731812,
      0.8292885422706604,
      1.000000238418579,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6836391687393188,
      0.6688234806060791,
      0.6080833077430725,
      0.6056203246116638,
      0.689544677734375,
      1.000000238418579,
      1.0,
      1.0,
      0.8320006132125854,
      0.8169856071472168,
      1.0,
      1.0,
      0.9129931926727295,
      0.9031563401222229,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.903645396232605,
      0.8473215699195862,
      1.0,
      1.0000001192092896,
      0.8125427961349487,
      0.7383591532707214,
      0.7583372592926025,
      1.0,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.9736135005950928,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0,
      0.8812066912651062,
      1.0,
      1.0000001192092896,
      0.6494263410568237,
      0.6765936613082886,
      1.0000001192092896
    ],
    "question_types": [
      "symptom",
      "diagnosis"
    ],
    "umls_normalized_entities": [
      "Mental and behavioral disorders due to use of opioids, acute intoxication",
      "Alzheimer disease (Ezihaimo disease)",
      "Occipital subdural hematoma",
      "Winnick's encephalopathy (Wernicke's encephalopathy)",
      "Mental Depression"
    ],
    "umls_semantic_variants": [
      [
        "acute mental disorders",
        "Mental and behavioural disorders due to use of opioids, acute intoxication",
        "Psychische stoornissen en gedragsstoornissen door gebruik van opio\u00efden; Acute intoxicatie"
      ],
      [
        "Alzheimer disease (Ezihaimo disease)"
      ],
      [
        "Subdural hematoma",
        "Occipital subdural hematoma",
        "Occipital subdural haematoma"
      ]
    ],
    "enhanced_entity_links": {},
    "adaptive_knowledge_count": 78,
    "hierarchical_contexts": {
      "acute mental disorders": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      },
      "Alzheimer disease (Ezihaimo disease)": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      },
      "Subdural hematoma": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      }
    },
    "multi_hop_paths_count": 0
  },
  {
    "id": "699",
    "question_id": "699",
    "document_id": "699",
    "question": "Which of the following elements nerve conduction disorders, generally considered to be Azihaimo disease (Alzheimer's disease) the main cause?",
    "type": "multiple_choice",
    "choices": [
      "Dopamine (dopamine)",
      "Acetylcholine (acetylcholine)",
      "Serotonin (serotonin)",
      "Substance P (substance P)"
    ],
    "context": "",
    "answer": [
      "Acetylcholine (acetylcholine)"
    ],
    "entity": "1. nerve conduction disorders\n2. Azihaimo disease (Alzheimer's disease)\n3. dopamine\n4. acetylcholine\n5. serotonin\n6. substance P",
    "prediction": "B",
    "path": "Reranked Triple1: Substance P (SP) \u2014\u2014> has \u2014\u2014> neurotoxic  \nReranked Triple2: neurotoxic \u2014\u2014> causes \u2014\u2014> AD  \nReranked Triple3: AD \u2014\u2014> associated with \u2014\u2014> Abeta42  \nReranked Triple4: Abeta42 \u2014\u2014> consists of \u2014\u2014> leucine  \nReranked Triple5: Alzheimer's-type dementia \u2014\u2014> associates \u2014\u2014> cognitive impairment  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple4: AD \u2014\u2014> CAUSES \u2014\u2014> cognitive impairment  \nReranked Triple5: Alzheimer's amyloidosis \u2014\u2014> TYPE \u2014\u2014> neurodegenerative disease  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Substance P (SP)' 'has' 'neurotoxic' properties.  \nPath-based Evidence 2: 'Neurotoxic' 'causes' 'Alzheimer's Disease (AD)'.  \nPath-based Evidence 3: 'Alzheimer's Disease (AD)' 'is associated with' 'Abeta42'.  \nPath-based Evidence 4: 'Abeta42' 'consists of' 'leucine'.  \nPath-based Evidence 5: 'Alzheimer's-type dementia' 'associates with' 'cognitive impairment'.  ",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 4: 'AD' 'CAUSES' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'Alzheimer's amyloidosis' 'TYPE' 'neurodegenerative disease'.",
    "entity_confidence_scores": [
      0.6971548795700073,
      0.6839916706085205,
      0.8024044632911682,
      1.000000238418579,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      1.0000001192092896,
      1.0,
      1.0,
      0.7817915081977844,
      0.7523283958435059,
      0.7523283958435059,
      1.0000001192092896,
      0.9878115057945251,
      1.0000001192092896,
      1.0,
      0.910812497138977,
      0.7877157926559448,
      0.7492498159408569,
      0.8557859659194946,
      1.0,
      1.0,
      0.9129931926727295,
      0.9031563401222229,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.903645396232605,
      0.8473215699195862,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      0.7383591532707214,
      0.7583372592926025,
      1.0,
      1.0,
      1.0000001192092896,
      1.0,
      0.8520411252975464,
      0.8520411252975464,
      1.0000001192092896,
      0.8533504009246826,
      0.7750062346458435,
      0.8702182769775391,
      1.0000001192092896,
      0.9736135005950928,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0,
      0.8812066912651062,
      1.0,
      1.0000001192092896,
      0.7188719511032104,
      1.0,
      1.0000001192092896,
      0.7756879329681396,
      0.7607340216636658,
      0.7607340216636658,
      0.6973281502723694,
      1.0000001192092896
    ],
    "question_types": [
      "causation",
      "definition"
    ],
    "umls_normalized_entities": [
      "Abnormal nerve conduction",
      "Azihaimo disease (Alzheimer's disease)",
      "dopamine",
      "acetylcholine",
      "serotonin",
      "Substance P"
    ],
    "umls_semantic_variants": [
      [
        "nerve conduction disorders",
        "Abnormal nerve conduction",
        "conducci\u00f3n nerviosa anormal (hallazgo)"
      ],
      [
        "Azihaimo disease (Alzheimer's disease)"
      ],
      [
        "dopamine",
        "4-(2-Aminoethyl)-1,2-benzenediol",
        "4-(2-aminoethyl)catechol"
      ]
    ],
    "enhanced_entity_links": {},
    "adaptive_knowledge_count": 139,
    "hierarchical_contexts": {
      "nerve conduction disorders": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      },
      "Azihaimo disease (Alzheimer's disease)": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      },
      "dopamine": {
        "diseases": [],
        "symptoms": [],
        "treatments": []
      }
    },
    "multi_hop_paths_count": 0
  }
]